Overexpression of HO-1 has been reported in lymphosarcoma (35), brain tumors (36), renal carcinoma (37), hepatoma (38), Kaposi sarcoma (39), pancreatic cancer (40) and chronic myeloid leukemia (41). Here, HMOX1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.